<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01844206</url>
  </required_header>
  <id_info>
    <org_study_id>AAAL3857</org_study_id>
    <nct_id>NCT01844206</nct_id>
  </id_info>
  <brief_title>Two Dose Epidural Morphine for Post-cesarean Analgesia</brief_title>
  <official_title>Two Dose Epidural Morphine for Post-cesarean Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen
      for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes
      scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that
      administration of a second dose of epidural morphine 3 mg, 24 hours after an initial
      intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours
      after surgery, compared to a single epidural morphine dose regimen. The primary outcome will
      be the amount of intravenous morphine patients self-administer during the 2nd 24 hours
      post-surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomized, double-blinded placebo-controlled study. In this study, women who
      underwent cesarean section with epidural anesthesia will receive 3 mg of epidural morphine
      intraoperatively, and have the epidural catheter left in place. Patients will be randomized
      to receive either epidural saline or epidural morphine 3 mg at 18 - 24 hours after the first
      dose of epidural morphine, following which the epidural catheter will be removed. It is
      standard of care at our institution for women undergoing cesarean section with epidural
      anesthesia to receive epidural morphine 3 mg. What is not typically carried out is to give a
      second dose of epidural morphine 3mg.

      The randomization will be carried out by a computerized block randomization table; the
      proportion for the 2 groups will be 1:1. The primary outcome will be the amount of
      intravenous morphine patients self-administer in the second 24 hours after surgery. Secondary
      outcomes will include pain scores every 6 hours, satisfaction with analgesia, side effects
      (itching, nausea/vomiting).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow recruitment of subjects
  </why_stopped>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Average Amount of Intravenous Morphine Patients Self-administered in the Second 24 Hours Post-surgery</measure>
    <time_frame>Up to 48 hours post-operatively</time_frame>
    <description>The primary outcome of this study is the amount (mg) of morphine self-administered by PCA pump during the second 24 hours after surgery. This will be compared by unpaired t-test for two groups.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Pain</condition>
  <condition>Morphine Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Epidural Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural Morphine</intervention_name>
    <description>Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
    <arm_group_label>Epidural Morphine</arm_group_label>
    <other_name>DepoDur</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural Saline</intervention_name>
    <description>Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
    <arm_group_label>Epidural Saline</arm_group_label>
    <other_name>Sodium Chloride Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing cesarean section under epidural anesthesia.

        Exclusion Criteria:

          -  Emergent cesarean section

          -  Coagulopathy

          -  Failed epidural anesthesia or patchy block

          -  General anesthesia

          -  Use of epidural chloroprocaine

          -  Allergy or contraindication to Non-steroidal anti-inflammatory drug (NSAIDs)

          -  Severe opioid side effects

          -  History of chronic opioid use

          -  History of chronic pain

          -  History of obstructive sleep apnea

          -  Morbid obesity (Body Mass Index (BMI)&gt;45 kg/m2)

          -  Height under 4' 10&quot; (147 cm)

          -  Documented dural puncture by the epidural (Tuohy) needle

          -  Preeclampsia

          -  Other significant medical disease (American Society of Anesthesiologists (ASA) 3 or
             more).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allison Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Zakowski MI, Ramanathan S, Turndorf H. A two-dose epidural morphine regimen in cesarean section patients: pharmacokinetic profile. Acta Anaesthesiol Scand. 1993 Aug;37(6):584-9.</citation>
    <PMID>8213024</PMID>
  </reference>
  <reference>
    <citation>Palmer CM, Nogami WM, Van Maren G, Alves DM. Postcesarean epidural morphine: a dose-response study. Anesth Analg. 2000 Apr;90(4):887-91.</citation>
    <PMID>10735794</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2013</study_first_submitted>
  <study_first_submitted_qc>April 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2013</study_first_posted>
  <results_first_submitted>October 16, 2015</results_first_submitted>
  <results_first_submitted_qc>November 19, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 23, 2015</results_first_posted>
  <last_update_submitted>November 19, 2015</last_update_submitted>
  <last_update_submitted_qc>November 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Allison Lee</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Post-cesarean analgesia</keyword>
  <keyword>Second dose of epidural morphine after surgery</keyword>
  <keyword>Post-operative analgesia</keyword>
  <keyword>Self-administered epidural morphine</keyword>
  <keyword>Pain management after cesarean</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Epidural Morphine</title>
          <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose
Epidural Morphine: Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
        </group>
        <group group_id="P2">
          <title>Epidural Saline</title>
          <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.
Epidural Saline: Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2">One patient requested that epidural catheter be removed during the first post-operative day.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Epidural Morphine</title>
          <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose
Epidural Morphine: Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
        </group>
        <group group_id="B2">
          <title>Epidural Saline</title>
          <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.
Epidural Saline: Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Average Amount of Intravenous Morphine Patients Self-administered in the Second 24 Hours Post-surgery</title>
        <description>The primary outcome of this study is the amount (mg) of morphine self-administered by PCA pump during the second 24 hours after surgery. This will be compared by unpaired t-test for two groups.</description>
        <time_frame>Up to 48 hours post-operatively</time_frame>
        <population>Data could not be summarized to include in the data table because only 5 out of 140 subjects were enrolled prior to study termination, and no data analysis was carried out. As instructed, we are specifying zero (&quot;0&quot;) for the Number of Participants Analyzed in each Arm/Group and leaving the data fields blank.</population>
        <group_list>
          <group group_id="O1">
            <title>Epidural Morphine</title>
            <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose
Epidural Morphine: Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
          </group>
          <group group_id="O2">
            <title>Epidural Saline</title>
            <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.
Epidural Saline: Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>The Average Amount of Intravenous Morphine Patients Self-administered in the Second 24 Hours Post-surgery</title>
          <description>The primary outcome of this study is the amount (mg) of morphine self-administered by PCA pump during the second 24 hours after surgery. This will be compared by unpaired t-test for two groups.</description>
          <population>Data could not be summarized to include in the data table because only 5 out of 140 subjects were enrolled prior to study termination, and no data analysis was carried out. As instructed, we are specifying zero (&quot;0&quot;) for the Number of Participants Analyzed in each Arm/Group and leaving the data fields blank.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 48 hours post-surgery</time_frame>
      <desc>Women undergoing cesarean section under epidural anesthesia virtually always receive epidural morphine for post-operative analgesia. The 5 women did not experience any unexpected/reportable serious or non-serious adverse effects from the epidural morphine after cesarean section.</desc>
      <group_list>
        <group group_id="E1">
          <title>Epidural Morphine</title>
          <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose
Epidural Morphine: Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
        </group>
        <group group_id="E2">
          <title>Epidural Saline</title>
          <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.
Epidural Saline: Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Allison Lee</name_or_title>
      <organization>Columbia University</organization>
      <phone>305-582-6077</phone>
      <email>al3196@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

